CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Cytek Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$5.25+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $679.67M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cytek Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 24, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | Jun 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2025 | Apr 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2024 | Sep 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2024 | Jun 11, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2024 | Apr 25, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2024 | Mar 19, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 13, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2024 | Mar 1, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2024 | Feb 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 9, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2023 | Nov 28, 2023 | SEC EDGAR |